Loading interface...

Lorlip-LS Tablet

Manufactured byUNICHEM LABORATORIES LTD
ContainsAtorvastatin (10 mg) + Fenofibrate (80 mg)
Description
Lorlip-LS Tablet is a combination of Atorvastatin and Fenofibrate. It is used for the treatment of hyperlipidemia (high levels of fat) and the prevention of heart attack. It works by lowering the bad cholesterol and increases the level of good cholesterol in your body. Lorlip-LS Tablet may show some side effects like runny nose, sneezing, diarrhoea, headache and joint pain. These side effects subside on their own as your body starts adapting to this medicine. Consult your doctor if any side effects persist or worsen. It is recommended that you avoid taking this medicine if previously allergic to it. Lorlip-LS Tablet can be taken with or without food. For the ease of remembering, take this medicine around the same time every day. Do not stop taking this medicine unless your doctor tells you to do so. Abrupt discontinuation may worsen your condition. Lorlip-LS Tablet may interact with the action of other medicines. Inform your doctor about any other health issues like liver, kidney, heart troubles or if you are undergoing any medical treatment before taking this medicine. Consult your doctor before taking this medicine if you are pregnant, planning to become pregnant, or are breastfeeding.

Side effects

Major & minor side effects for Lorlip-LS Tablet

  • Difficulty in breathing
  • Chills and fever
  • Itching and skin rash
  • Nausea and Vomiting
  • Headache
  • Shortness of breath
  • Weakness
  • Stuffy Nose
  • Difficulty in swallowing
  • Diarrhoea
  • Joint pain
  • Muscle pain
  • Increase in blood glucose level
  • Slow heart rate

Uses of Lorlip-LS Tablet

What is it prescribed for?

  • Hyperlipidemia
  • Prevention of heart Attack
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken for Lorlip-LS Tablet to show its effect is not known.
  • How long do the effects of this medicine last?
    The duration for which Lorlip-LS Tablet remains active in your body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported for Lorlip-LS Tablet.
  • Can this medicine be taken during pregnancy?
    Lorlip-LS Tablet is usually not advised during pregnancy since it might have significant side effects on your foetus. However, if you are pregnant your doctor may prescribe alternative medicine with the same medicinal effect.
  • Can this medicine be taken while breast-feeding?
    Lorlip-LS Tablet is not recommended during breastfeeding as it may affect your infant.

Allergy

Avoid taking Lorlip-LS Tablet if you are previously allergic to it. Seek immediate medical attention if you notice any symptoms of allergic reactions such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulties, etc.

Kidney Disease

Lorlip-LS Tablet is not recommended for use if you have kidney troubles. This medicine is exerted through urine and improper kidney function may lead to its accumulation in your body. It may further lead to rhabdomyolysis (leakage of muscle contents into the blood circulation) and severe hyperkalemia (high level of potassium in your blood).

Gallbladder disease

Lorlip-LS Tablet is not recommended for use if you have a known history of gallbladder diseases due to the increased risk of gallbladder stones.

Liver disease

Lorlip-LS Tablet is contraindicated in liver diseases like biliary cirrhosis (a disease that harms the liver's ability to function). This medicine may further raise the already elevated levels of cholesterol in your body.
Warnings for special population

Pregnancy

Lorlip-LS Tablet is usually not advised during pregnancy since it might have significant side effects on your foetus. However, if you are pregnant your doctor may prescribe alternative medicine with the same medicinal effect.

Breast-feeding

Lorlip-LS Tablet is not recommended during breastfeeding as it may affect your infant.
General warnings

Alcohol consumption

Lorlip-LS Tablet may cause liver and kidney injuries if you consume alcohol very frequently and in large quantities. Hence, consumption of alcohol should be avoided during treatment with this medicine.

Use in pediatrics

Lorlip-LS Tablet is not recommended for use in children since the safety and efficacy of use are not clinically established.

Hematologic Changes

Lorlip-LS Tablet should be used with caution due to the risk of a decrease in the haemoglobin and white blood cell counts.

Concomitant Oral Anticoagulants

Lorlip-LS Tablet should be used with caution if you are taking anticoagulant medicines (blood thinner) due to the increased risk of excessive bleeding.

Missed Dose

If you forget to take a dose of Lorlip-LS Tablet, take it as soon as you remember. If it is almost time for your next, skip the missed dose. Do not take two doses together to make up for a missed dose.

Overdose

Never take more than the prescribed dose of Lorlip-LS Tablet. If you suspect that you might have taken an overdose of this medicine, go to the nearer emergency medical department/hospital.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Clarithromycin

Azithromycin

Atazanavir

Cyclosporine

Disease interactions

Cognitive Impairment

Cognitive impairment is a condition in which you have difficulty remembering, learning new things, focusing, or making decisions. Lorlip-LS Tablet should be used with caution if you have such a condition because it may worsen your condition.

Diabetes

Diabetes is a condition in which there is an increase in blood sugar levels. Lorlip-LS Tablet may interfere with your blood sugar control.

Rhabdomyolysis

Rhabdomyolysis is a condition in which muscle tissue and proteins enter the bloodstream due to muscle injury. It may lead to kidney failure and other problems. Lorlip-LS Tablet should be used with caution if you have rhabdomyolysis because it may worsen your condition.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with Lorlip-LS Tablet due to the increased risk of adverse effects such as dizziness, muscle pain, fever and chills, headache, swelling of hands and feet, vomiting, skin rash, etc.
Lab interactions
Information not available.
Take Lorlip-LS Tablet as advised by your doctor. It can be taken with or without food. Consult the doctor if you experience any side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Lorlip-LS Tablet is a combination of Atorvastatin and Fenofibrate. Atorvastatin reduces the level of cholesterol in your blood. Fenofibrate removes the bad cholesterol (LDL) and triglycerides (fats) from the blood and increases the levels of good cholesterol (HDL).
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Statins, Fibric acid derivatives, Antihyperlipidemic combinations

Schedule

Schedule H

Pubchem.ncbi.nlm.nih.gov. 2021. Fenofibrate. [online] Available at: < [Accessed 7 September 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/3339>

Pubchem.ncbi.nlm.nih.gov. 2021. Atorvastatin. [online] Available at: < [Accessed 13 May 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Atorvastatin>

Medicines.org.uk. 2021. Atorvastatin 10 mg Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 19 August 2021].

https://www.medicines.org.uk/emc/product/11199#INDICATIONS>

Medicines.org.uk. 2021. Fenofibrate 160mg Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 7 September 2021].

https://www.medicines.org.uk/emc/product/5267/smpc>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 16 Sep 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.